![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Aerogen Combination Product Receives Fast-Track Designation
Aerogen Combination Product Receives Fast-Track Designation
The FDA has given fast-track designation to Aerogen's Amikacin Pulmonary Delivery System for Ventilator-Associated Pneumonia (VAP).
The delivery system is a combination product that uses the company's Aerosol Generator technology to deliver high efficiency aerosol to patients on mechanical ventilators.
According to the company, the FDA granted its product fast-track designation because of the high mortality rate associated with VAP and because Aerogen's product "offers the possibility of reducing systemic toxicity."
KEYWORDS Drug Pipeline Alert
Upcoming Events
-
11Jul
-
18Jul
-
21Oct